221 related articles for article (PubMed ID: 34843158)
1. Causal effects from non-alcoholic fatty liver disease on kidney function: A Mendelian randomization study.
Park S; Lee S; Kim Y; Cho S; Kim K; Chul Kim Y; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
Liver Int; 2022 Feb; 42(2):412-418. PubMed ID: 34843158
[TBL] [Abstract][Full Text] [Related]
2. A two-sample mendelian randomization analysis excludes causal relationships between non-alcoholic fatty liver disease and kidney stones.
Li X; Xie Y; Tang L; Li D; Wang J; Sheng H; Chen K; Xiao S; Li J; Yang M
Front Endocrinol (Lausanne); 2023; 14():1343367. PubMed ID: 38269249
[TBL] [Abstract][Full Text] [Related]
3. Type 1 diabetes mellitus and non-alcoholic fatty liver disease: a two-sample Mendelian randomization study.
Tuo L; Yan LT; Liu Y; Yang XX
Front Endocrinol (Lausanne); 2024; 15():1315046. PubMed ID: 38681765
[TBL] [Abstract][Full Text] [Related]
4. Causal relationship between sleep apnea and non-alcoholic fatty liver disease: A Mendelian randomization study.
Zhang Z; Li M; Ji G; Zhang L
Eur J Clin Invest; 2024 Mar; 54(3):e14116. PubMed ID: 37916519
[TBL] [Abstract][Full Text] [Related]
5. Serum Uric Acid Levels and Nonalcoholic Fatty Liver Disease: A 2-Sample Bidirectional Mendelian Randomization Study.
Li S; Fu Y; Liu Y; Zhang X; Li H; Tian L; Zhuo L; Liu M; Cui J
J Clin Endocrinol Metab; 2022 Jul; 107(8):e3497-e3503. PubMed ID: 35363278
[TBL] [Abstract][Full Text] [Related]
6. Serum 25-hydroxyvitamin D levels and the risk of non-alcoholic fatty liver: A two-sample Mendelian randomization study.
Sheng Q; Shi H; Liu S; Zhuang L; Zhao Z; Xin Y
Saudi J Gastroenterol; 2023; 29(1):39-46. PubMed ID: 36254930
[TBL] [Abstract][Full Text] [Related]
7. Habitual coffee intake and risk for nonalcoholic fatty liver disease: a two-sample Mendelian randomization study.
Zhang Y; Liu Z; Choudhury T; Cornelis MC; Liu W
Eur J Nutr; 2021 Jun; 60(4):1761-1767. PubMed ID: 32856188
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic fatty liver disease and cardiovascular diseases: A Mendelian randomization study.
Peng H; Wang S; Wang M; Ye Y; Xue E; Chen X; Wang X; Fan M; Gao W; Qin X; Wu Y; Chen D; Li J; Hu Y; Wang L; Wu T
Metabolism; 2022 Aug; 133():155220. PubMed ID: 35618017
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic fatty liver disease and type 2 diabetes: an observational and Mendelian randomization study.
Yu Y; Yu Y; Wang Y; Chen Y; Wang N; Wang B; Lu Y
Front Endocrinol (Lausanne); 2023; 14():1156381. PubMed ID: 37223039
[TBL] [Abstract][Full Text] [Related]
10. Nonlinear causal effects of estimated glomerular filtration rate on myocardial infarction risks: Mendelian randomization study.
Park S; Lee S; Kim Y; Cho S; Huh H; Kim K; Kim YC; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
BMC Med; 2022 Feb; 20(1):44. PubMed ID: 35109828
[TBL] [Abstract][Full Text] [Related]
11. Non-Alcoholic Fatty Liver Disease and Vitamin D in the UK Biobank: A Two-Sample Bidirectional Mendelian Randomisation Study.
Zhang Z; Burrows K; Fuller H; Speliotes EK; Abeysekera KWM; Thorne JL; Lewis SJ; Zulyniak MA; Moore JB
Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986172
[TBL] [Abstract][Full Text] [Related]
12. Causal association of NAFLD with osteoporosis, fracture and falling risk: a bidirectional Mendelian randomization study.
Cui A; Xiao P; Fan Z; Lei J; Han S; Zhang D; Wei X; Wang P; Zhuang Y
Front Endocrinol (Lausanne); 2023; 14():1215790. PubMed ID: 37621646
[TBL] [Abstract][Full Text] [Related]
13. The associations of alcoholic liver disease and nonalcoholic fatty liver disease with bone mineral density and the mediation of serum 25-Hydroxyvitamin D: A bidirectional and two-step Mendelian randomization.
Huang Q; Guo J; Zhao H; Zheng Y; Zhang Y
PLoS One; 2023; 18(10):e0292881. PubMed ID: 37856513
[TBL] [Abstract][Full Text] [Related]
14. Homocysteine, folate, and nonalcoholic fatty liver disease: a systematic review with meta-analysis and Mendelian randomization investigation.
Yuan S; Chen J; Dan L; Xie Y; Sun Y; Li X; Larsson SC
Am J Clin Nutr; 2022 Dec; 116(6):1595-1609. PubMed ID: 36205540
[TBL] [Abstract][Full Text] [Related]
15. Associations of non-alcoholic fatty liver disease and cirrhosis with liver cancer in European and East Asian populations: A Mendelian randomization study.
Deng Y; Huang J; Wong MCS
Cancer Rep (Hoboken); 2024 Jan; 7(1):e1913. PubMed ID: 37840448
[TBL] [Abstract][Full Text] [Related]
16. Atrial fibrillation and kidney function: a bidirectional Mendelian randomization study.
Park S; Lee S; Kim Y; Lee Y; Kang MW; Kim K; Kim YC; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
Eur Heart J; 2021 Jul; 42(29):2816-2823. PubMed ID: 34023889
[TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic fatty liver disease and complications in type 1 and type 2 diabetes: A Mendelian randomization study.
Liu N; Wang G; Liu C; Liu J; Huang S; Zhou Y; Xiao E
Diabetes Obes Metab; 2023 Feb; 25(2):365-376. PubMed ID: 36181433
[TBL] [Abstract][Full Text] [Related]
18. Causal Effects of Positive Affect, Life Satisfaction, Depressive Symptoms, and Neuroticism on Kidney Function: A Mendelian Randomization Study.
Park S; Lee S; Kim Y; Lee Y; Kang MW; Kim K; Kim YC; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
J Am Soc Nephrol; 2021 Jun; 32(6):1484-1496. PubMed ID: 33785582
[TBL] [Abstract][Full Text] [Related]
19. Circulating Galectin-3 Levels Are Not Associated With Nonalcoholic Fatty Liver Disease: A Mendelian Randomization Study.
Tremblay M; Perrot N; Ghodsian N; Gobeil É; Couture C; Mitchell PL; Thériault S; Arsenault BJ
J Clin Endocrinol Metab; 2021 Jul; 106(8):e3178-e3184. PubMed ID: 33693708
[TBL] [Abstract][Full Text] [Related]
20. Non-alcoholic fatty liver disease and gestational diabetes mellitus: a bidirectional two-sample mendelian randomization study.
Zhou BG; Xia JL; Jiang X; Ding YB; She Q
BMC Endocr Disord; 2024 Mar; 24(1):40. PubMed ID: 38504196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
